FDA Inspection 1229822 — The Blood Center
The FDA completed an inspection of The Blood Center on August 16, 2024 in Hammond, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hammond, LA (United States)